Citius Oncology Inc (CTOR) Stock Price, Quote & News

Company Profile

Citius Oncology, Inc. focuses on the development and commercialization of innovative targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. operates as a subsidiary of Citius Pharmaceuticals, Inc.

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: (908) 967-6677

Address:

11 Commerce Drive, First Floor, Cranford, United States

BullsEyePick Oct. 2 at 4:57 AM

Looking for the next Monster runner?🚨🚨 Make sure you have ticker IVDA on ur watch. IVDA is Truly a gem of a ticker, known for big runs and perfect for a market like this where this can go on a massive rally of 400-500%+. IVDA has everything going for it, news/approved crypto treasury/Ai /Drone and most important of all it's a low float ticker. Be early bulls, because it will take off fast!! Watching $CJET $FLD $QLGN $CTOR

0 · Reply

900fix Oct. 1 at 10:15 PM

$CTOR How can someone screw up so much and still be running a company?

0 · Reply

donein12 Oct. 1 at 7:51 PM

$CTOR Really funny. CTOR raised money and is close to the 1st sales, and CTXR (the parent) needs cash, is not anywere near of commercializtion of ML or any others in their pipline,But CTXR is strong on the up up side today and CTOR is the one being sold. Try and fiqure that one out. LOL.

0 · Reply

SweStonk Sep. 30 at 7:12 PM

$CTOR Why no launch? 1 year ago they could have easily raised enough funding to make the launch happen. I think many agree on that this is one of the slowest launch since forever. Why? They have shares to sell to get funding. CTXR could sell some of the shares to fund it. But they wont? Why or what could they possibly gain from delay after delay? I can think of one reason only, they know sales will be bad. Current mkt cap is way way higher than what it will be when we finally see what they are able to make from lymphir(Remember it is third in line with 2 approved treatments on the market with better efficincy) So they drag out on everything, FDA approval should have been a slamdunk still it failed, launch would have been easy, they have 2 options to sell shares to get funding but still they only raise enough to keep lights on? WHY? Because while we wait they print free shares to themselves. The slower it goes the more awarded shares for them until it all come falling down.

0 · Reply

donein12 Sep. 29 at 9:37 AM

$CTOR Just my opinion: Expecting a good week for CTOR since Wed. is the 1st day of Qtr. 4,and possible buying may be strong Mon/Tues in anticipation of sales that are expected in the 4th qtr. Not implying sales will be on the 1st but CTOR sales are expected in the 4th QTR., so any day is possible. Of course Mazur is the CEO, so he may move it to the 1st Qtr. of 2026. LOL!!

0 · Reply

StockHounding Sep. 27 at 7:11 PM

$MIGI and $VTYX are bullish after Friday $PAVS no 1 pick Monday Get in early $PCSA boom $CTOR happening again

0 · Reply

TwongStocks Sep. 26 at 8:40 PM

$CTOR Forgot to mention. Since CTXR owns 79% of CTOR shares, all proposals are going to pass. I doubt CTXR is voting NO on anything.

1 · Reply

TwongStocks Sep. 26 at 8:36 PM

$CTOR Proxy for annual meeting. https://www.sec.gov/ix?doc=/Archives/edgar/data/1851484/000121390025092369/ea0257805-def14a_citius.htm Meeting is Oct 27. Shareholders of record on Sept 19 are entitled to vote. There were 83,513,442 shares outstanding on the record date. Proposals: 1) Election of Class I Directors (Holubiak and Mayersohn) 2) Approve amendment to increase shares reserved under the Omnibus Stock Incentive Plan from 15m to 30m. 3) Ratify Wolf & Company as independent auditor

0 · Reply

Eroc Sep. 26 at 6:46 PM

$CTOR she's trying! c'mon bulls let's move this one!

0 · Reply

BALUGA825 Sep. 26 at 6:46 PM

$CTOR Will it close over 2 for the weekend? $CTXR

0 · Reply

Citius Oncology Announces Closing of $9.0 Million Registered Direct Offering and Concurrent Private Placement

CTXR

Sep 9, 2025, 8:30 AM EDT - 25 days ago

Citius Oncology Announces Pricing of $9.0 Million Registered Direct Offering and Concurrent Private Placement

CTXR

Aug 22, 2025, 8:47 AM EDT - 6 weeks ago

Citius Oncology Deploys AI Platform to Amplify the Performance of its Commercial Team Ahead of LYMPHIR Launch

CTXR

Aug 12, 2025, 4:30 PM EDT - 7 weeks ago

Citius Oncology, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update

Jul 17, 2025, 4:30 PM EDT - 2 months ago

Citius Oncology Announces Closing of $9.0 Million Public Offering

CTXR

Jul 16, 2025, 9:15 AM EDT - 2 months ago

Citius Oncology Announces Pricing of $9.0 Million Public Offering

CTXR

Jul 15, 2025, 8:32 AM EDT - 2 months ago

Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora

CTXR

Jun 17, 2025, 8:08 AM EDT - 3 months ago

Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025

CTXR

May 14, 2025, 4:30 PM EDT - 5 months ago

Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update

May 5, 2025, 8:37 AM EDT - 5 months ago

Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

CTXR

Feb 14, 2025, 4:30 PM EST - 8 months ago

Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

CTXR

Feb 14, 2025, 4:30 PM EST - 8 months ago

Citius Oncology, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

Feb 6, 2025, 8:55 AM EST - 8 months ago

Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services

CTXR

Jan 7, 2025, 8:08 AM EST - 9 months ago

Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025

CTXR

Jan 6, 2025, 7:50 AM EST - 9 months ago

Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives

CTXR

Dec 27, 2024, 5:00 PM EST - 10 months ago

Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update

BullsEyePick Oct. 2 at 4:57 AM

0 · Reply

900fix Oct. 1 at 10:15 PM

$CTOR How can someone screw up so much and still be running a company?

0 · Reply

donein12 Oct. 1 at 7:51 PM

0 · Reply

SweStonk Sep. 30 at 7:12 PM

0 · Reply

donein12 Sep. 29 at 9:37 AM

0 · Reply

StockHounding Sep. 27 at 7:11 PM

$MIGI and $VTYX are bullish after Friday $PAVS no 1 pick Monday Get in early $PCSA boom $CTOR happening again

0 · Reply

TwongStocks Sep. 26 at 8:40 PM

$CTOR Forgot to mention. Since CTXR owns 79% of CTOR shares, all proposals are going to pass. I doubt CTXR is voting NO on anything.

1 · Reply

TwongStocks Sep. 26 at 8:36 PM

0 · Reply

Eroc Sep. 26 at 6:46 PM

$CTOR she's trying! c'mon bulls let's move this one!

0 · Reply

BALUGA825 Sep. 26 at 6:46 PM

$CTOR Will it close over 2 for the weekend? $CTXR

0 · Reply

donein12 Sep. 26 at 5:04 PM

$CTOR Just my opinion: I am expecting a good week for CTOR next week due the fact that Wed. is the 1st day of Qtr. 4. whereas buying may be strong Mon/Tues in anticipation of sales that are expected in the 4th qtr. Not implying sales will be on the 1st but CTOR will be in the 4th QTR., so any day is possible. Of course Mazur is the CEO, so he may move it to the 1st Qtr. of 2026. LOL!!

0 · Reply

Eroc Sep. 26 at 3:41 PM

$CTOR c'mon let's get some volume behind this ticker!

0 · Reply

OkieDokieTrader Sep. 25 at 7:06 PM

$CTOR What’s the buyers and sellers waiting on for this? Just curious, the consolidation in price is nasty! When it goes, there should be a lot of energy behind it. Anyone actually been following the company give some insight?

1 · Reply

donein12 Sep. 24 at 7:28 PM

$CTOR CTOR hasn't traded for 37 minutes. What did they forget about CTOR!

2 · Reply

whathappenedtomyaccount Sep. 24 at 4:26 PM

$CTOR what i want to know is who does mazur know at maxim??

2 · Reply

SweStonk Sep. 24 at 10:44 AM

$CTOR $CTXR Lenny the scumbag shit on its investors. He will continue this scam with dilution after dilution without any result and push back timeline after timeline. He have done it for YEARS now. You want to make money? Go look somewhere else cause the only one making money here is Lenny. Not a single result or timeline held for years and years. This is written scam all over it.

0 · Reply

sokrodney Sep. 24 at 12:44 AM

$CTOR is it this one?!?! Maybe?!?! Will see!

0 · Reply

900fix Sep. 23 at 11:43 PM

$CTOR So Lenny tries to run this up to $10 and he gets 17 Million back then dumps it . What a scam.

0 · Reply

TwongStocks Sep. 23 at 8:52 PM

$CTOR Leonard granted 1.7m RSUs https://www.sec.gov/Archives/edgar/data/1851484/000121390025090614/xslF345X05/ownership.xml Essentially 1.7m free CTOR shares. With regard to the distribution to $CTXR shareholders (if it ever happens)... While everyone else gets screwed with a smaller ratio each time CTXR dilutes, they can just give themselves free RSUs. They ensure they get a decent amount of shares of CTOR, regardless of what happens with the distro in the future.

5 · Reply

whathappenedtomyaccount Sep. 23 at 8:20 PM

$CTOR this place just cracks me up everytime i come

0 · Reply

Windwater Sep. 23 at 7:11 PM

$CTOR How much they need to hit so they can use that $200 m for IPO?

0 · Reply

BALUGA825 Sep. 23 at 2:17 PM

$CTOR Lez Go... $CTXR

0 · Reply

Market Cap	157.84M
Revenue (ttm)	0.00
Net Income (ttm)	-21.15M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.35

Volume	142,800
Avg Vol	328,960
Day's Range	N/A - N/A
Shares Out	83.51M
Stochastic %K	39%
Beta	2.92
Analysts	Strong Sell
Price Target	$6.00